CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 424B3 Offering Prospectus
- 8-K Event Code of ethics change · Other events
- S-1 Offering Registration Statement
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 424B3 Offering Prospectus
- 8-K Event Executive or director change
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- CT ORDER Other Confidential Order
- CT ORDER Other Confidential Order
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 37 of 41 · 809 filings